Beam Therapeutics (BEAM) Change in Cash (2019 - 2026)
Beam Therapeutics (BEAM) reported Change in Cash of -$6.6 million for Q1 2026, down 102.72% year-over-year from $244.4 million in Q1 2025, and down 124.57% on a QoQ basis from $27.0 million in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Change in Cash data on file, last reported at -$6.6 million in Q1 2026.
- Quarterly Change in Cash fell 102.72% year-over-year to -$6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$239.5 million (down 199.72% YoY) and the FY2025 annual result came in at $11.5 million, up 107.45% from the prior year.
- Change in Cash slipped to -$6.6 million in Q1 2026 per BEAM's latest filing, from $27.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $266.9 million in Q4 2023 and bottomed at -$263.2 million in Q1 2022.
- The 5-year median for Change in Cash is -$14.1 million (2025), against an average of -$16.3 million.
- Peak annual rise in Change in Cash reached 262.6% in 2025, while the deepest fall reached 5422.76% in 2025.
- Tracing BEAM's Change in Cash over 5 years: stood at $76.3 million in 2022, then surged by 249.97% to $266.9 million in 2023, then slumped by 80.01% to $53.4 million in 2024, then slumped by 49.39% to $27.0 million in 2025, then slumped by 124.57% to -$6.6 million in 2026.
- Per Business Quant, the three latest BEAM Change in Cash figures stand at -$6.6 million (Q1 2026), $27.0 million (Q4 2025), and -$14.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - | -6.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.64 Mn |
| Dec 31, 2025 | 27.00 Mn |
| Sep 30, 2025 | -14.15 Mn |
| Jun 30, 2025 | -245.75 Mn |
| Mar 31, 2025 | 244.41 Mn |
| Dec 31, 2024 | 53.36 Mn |
| Sep 30, 2024 | -62.17 Mn |
| Jun 30, 2024 | 4.62 Mn |
| Mar 31, 2024 | -150.31 Mn |
| Dec 31, 2023 | 266.89 Mn |
| Sep 30, 2023 | -63.24 Mn |
| Jun 30, 2023 | -18.61 Mn |
| Mar 31, 2023 | 14.05 Mn |
| Dec 31, 2022 | 76.26 Mn |
| Sep 30, 2022 | -109.11 Mn |
| Jun 30, 2022 | -31.20 Mn |
| Mar 31, 2022 | -263.17 Mn |
| Dec 31, 2021 | -54.12 Mn |
| Sep 30, 2021 | 400.01 Mn |
| Jun 30, 2021 | 114.77 Mn |
| Mar 31, 2021 | -64.93 Mn |
| Dec 31, 2020 | 24.27 Mn |
| Sep 30, 2020 | 14.11 Mn |
| Jun 30, 2020 | -748,000.00 |
| Mar 31, 2020 | 88.83 Mn |
| Dec 31, 2019 | -542,000.00 |
| Sep 30, 2019 | -86,000.00 |
| Jun 30, 2019 | -106.45 Mn |
| Mar 31, 2019 | 9.70 Mn |